-
Register
- Non-member - Free!
- Member - Free!
On Monday, October 17, at 12 PM CDT, ASTCT hosted its fourth webinar in the 2022 ASTCT CAR T Webinar Series. Drs. Jeremy Abramson and Mazyar Shadman will review the three phase 3 trials (ZUMA-7, TRANSFORM, BELINDA) and discuss how the clinical trial data can be applied to actual non-study patients. After the review of the trials and the data, Drs. Abramson and Shadman will engage in a panel discussion.
Moderator:
Dr. Antonio Vaz de Macedo; Head of the Hematology Clinic, Hospital da PolĂcia Militar, Brazil
Speakers:
Dr. Jeremy Abramson; Director, Jon and Jo Ann Hagler Center for Lymphoma, Massachusetts General Hospital Cancer Center. Associate Professor of Medicine, Harvard Medical School
Dr. Mazyar Shadman; Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.